ReachMD CME

CME credits: 0.25 Valid until: 16-06-2027 Claim your CME credit at https://reachmd.com/programs/cme/aace-guidance-hypercortisolism-adults-diabetes/50073/ Updated diabetes guidelines now recognize a new “other” category of diabetes linked to excess cortisol. This classification reflects emerging prevalence data showing that hypercortisolism may play a much larger role in diabetes development than p...

CME credits: 0.75 Valid until: 16-06-2027 Claim your CME credit at https://reachmd.com/programs/cme/unblocking-clinical-inertia-the-cmi-era-in-ohcm-care/56382/ Did you miss our symposium at ESC HF 2026? It’s not too late! This CME-accredited broadcast replay focuses on improving the diagnosis and management of obstructive hypertrophic cardiomyopathy (oHCM). Learn how to distinguish oHCM from heart...

CME credits: 0.25 Valid until: 15-06-2027 Claim your CME credit at https://reachmd.com/programs/cme/simple-diagnostic-steps-that-change-td-outcomes-increase-quality-of-life/54716/ This Podcast Plus discussion outlines standardized approaches to identifying and managing tardive dyskinesia. It reviews routine screening practices, use of tools such as AIMS, and key symptoms and timing in at-risk pati...

CME credits: 0.50 Valid until: 15-06-2027 Claim your CME credit at https://reachmd.com/programs/cme/ibd-masterclass-choosing-the-right-ibd-therapy-a-patient-clinician-connection/54374/ Join Drs. Odufalu and Iroku for this Patient-Clinician Connection, a case-based activity focused on optimizing management of inflammatory bowel disease. Through real-world patient dialogues in Crohn’s disease and ul...

CME credits: 0.75 Valid until: 08-06-2027 Claim your CME credit at https://reachmd.com/programs/cme/crossing-home-plate-building-a-winning-team-culture/56441/ This MinuteCE program brings a practical, team-based approach to improving atherosclerotic cardiovascular disease (ASCVD) prevention. Featuring expert multidisciplinary insights from Joseph Englert, MD, and Matt Malachowski, PharmD, this ser...

CME credits: 0.75 Valid until: 08-06-2027 Claim your CME credit at https://reachmd.com/programs/cme/turning-the-double-play-comprehensive-secondary-prevention/56440/ This MinuteCE program brings a practical, team-based approach to improving atherosclerotic cardiovascular disease (ASCVD) prevention. Featuring expert multidisciplinary insights from Joseph Englert, MD, and Matt Malachowski, PharmD, t...

CME credits: 0.75 Valid until: 08-06-2027 Claim your CME credit at https://reachmd.com/programs/cme/extra-innings-sustaining-victory-beyond-the-first-game/56439/ This MinuteCE program brings a practical, team-based approach to improving atherosclerotic cardiovascular disease (ASCVD) prevention. Featuring expert multidisciplinary insights from Joseph Englert, MD, and Matt Malachowski, PharmD, this...

CME credits: 0.75 Valid until: 08-06-2027 Claim your CME credit at https://reachmd.com/programs/cme/small-ball-wins-games-combination-therapy-for-goal-attainment/56438/ This MinuteCE program brings a practical, team-based approach to improving atherosclerotic cardiovascular disease (ASCVD) prevention. Featuring expert multidisciplinary insights from Joseph Englert, MD, and Matt Malachowski, PharmD...

CME credits: 0.75 Valid until: 08-06-2027 Claim your CME credit at https://reachmd.com/programs/cme/swing-for-the-fences-ldl-c-as-the-power-hitter/56437/ This MinuteCE program brings a practical, team-based approach to improving atherosclerotic cardiovascular disease (ASCVD) prevention. Featuring expert multidisciplinary insights from Joseph Englert, MD, and Matt Malachowski, PharmD, this series f...

CME credits: 0.75 Valid until: 08-06-2027 Claim your CME credit at https://reachmd.com/programs/cme/leadoff-hitter-spotting-high-risk-players/56435/ This MinuteCE program brings a practical, team-based approach to improving atherosclerotic cardiovascular disease (ASCVD) prevention. Featuring expert multidisciplinary insights from Joseph Englert, MD, and Matt Malachowski, PharmD, this series focuse...

CME credits: 0.50 Valid until: 23-07-2027 Claim your CME credit at https://reachmd.com/programs/cme/serena-6-acting-on-esr1-mutations-in-advanced-breast-cancer/57229/ Oral selective estrogen receptor degraders (SERDs) are rapidly reshaping the treatment landscape in breast cancer, offering targeted treatment approaches that have demonstrated improvements in progression-free survival and expanded o...

CME credits: 0.50 Valid until: 23-07-2027 Claim your CME credit at https://reachmd.com/programs/cme/ongoing-trials-in-oral-targeted-strategies-in-breast-cancer/57228/ Oral selective estrogen receptor degraders (SERDs) are rapidly reshaping the treatment landscape in breast cancer, offering targeted treatment approaches that have demonstrated improvements in progression-free survival and expanded o...

CME credits: 0.50 Valid until: 23-07-2027 Claim your CME credit at https://reachmd.com/programs/cme/elevate-elacestrant-plus-capivasertib-in-advanced-breast-cancer/57227/ Oral selective estrogen receptor degraders (SERDs) are rapidly reshaping the treatment landscape in breast cancer, offering targeted treatment approaches that have demonstrated improvements in progression-free survival and expand...

CME credits: 1.00 Valid until: 04-06-2027 Claim your CME credit at https://reachmd.com/programs/cme/a-q-challengetm-replay-advancing-precision-diagnosis-and-treatment-strategies-in-acromegaly/49278/ This broadcast replay from AACE 2026 features an interactive, case-based Q-Challenge format focused on acromegaly. Participants engage with clinical scenarios designed to assess and reinforce diagnosti...

CME credits: 0.25 Valid until: 03-06-2027 Claim your CME credit at https://reachmd.com/programs/cme/first-5-minutes-empowering-shared-decisions-in-lung-cancer-screening/50985/ This episode focuses on improving lung cancer screening and early detection by helping primary care providers recognize eligible and high-risk patients, apply current screening guidelines, and engage patients in clear shared...

CME credits: 2.00 Valid until: 30-06-2027 Claim your CME credit at https://reachmd.com/programs/cme/targeting-il-23-pathways-evolving-biologic-strategies-in-ibd/60779/ This 13-episode MinuteCE program examines contemporary treatment selection in inflammatory bowel disease, with emphasis on aligning therapy choice with disease phenotype, severity, prognosis, treatment goals, safety considerations,...

CME credits: 2.00 Valid until: 30-06-2027 Claim your CME credit at https://reachmd.com/programs/cme/gut-selective-therapy-understanding-anti-integrins-in-ibd/60778/ This 13-episode MinuteCE program examines contemporary treatment selection in inflammatory bowel disease, with emphasis on aligning therapy choice with disease phenotype, severity, prognosis, treatment goals, safety considerations, and...

CME credits: 2.00 Valid until: 30-06-2027 Claim your CME credit at https://reachmd.com/programs/cme/revisiting-anti-tnfs-role-risks-and-real-world-considerations/60777/ This 13-episode MinuteCE program examines contemporary treatment selection in inflammatory bowel disease, with emphasis on aligning therapy choice with disease phenotype, severity, prognosis, treatment goals, safety considerations,...

CME credits: 2.00 Valid until: 30-06-2027 Claim your CME credit at https://reachmd.com/programs/cme/beyond-one-size-fits-all-individualizing-first-line-ibd-treatment/60776/ This 13-episode MinuteCE program examines contemporary treatment selection in inflammatory bowel disease, with emphasis on aligning therapy choice with disease phenotype, severity, prognosis, treatment goals, safety considerati...

CME credits: 2.00 Valid until: 30-06-2027 Claim your CME credit at https://reachmd.com/programs/cme/where-conventional-ibd-therapies-fall-short/57256/ This 13-episode MinuteCE program examines contemporary treatment selection in inflammatory bowel disease, with emphasis on aligning therapy choice with disease phenotype, severity, prognosis, treatment goals, safety considerations, and patient-speci...

CME credits: 2.00 Valid until: 30-06-2027 Claim your CME credit at https://reachmd.com/programs/cme/defining-success-in-ibd-treat-to-target/57255/ This 13-episode MinuteCE program examines contemporary treatment selection in inflammatory bowel disease, with emphasis on aligning therapy choice with disease phenotype, severity, prognosis, treatment goals, safety considerations, and patient-specific...

CME credits: 1.00 Valid until: 02-06-2027 Claim your CME credit at https://reachmd.com/programs/cme/seeing-the-invisible-radiologic-precision-to-enable-early-intervention-in-bronchiectasis/56384/ Bronchiectasis is a chronic, progressive respiratory disease that is characterized by accelerated lung function decline and impaired quality of life, yet it remains substantially under recognized and unde...

CME credits: 2.00 Valid until: 30-06-2027 Claim your CME credit at https://reachmd.com/programs/cme/setting-the-stage-why-rethinking-ibd-care-matters-now/56325/ This 13-episode MinuteCE program examines contemporary treatment selection in inflammatory bowel disease, with emphasis on aligning therapy choice with disease phenotype, severity, prognosis, treatment goals, safety considerations, and pat...

CME credits: 0.25 Valid until: 01-06-2027 Claim your CME credit at https://reachmd.com/programs/cme/chairpersons-perspective-her2-in-solid-tumors-from-pathology-to-personalized-treatment-plans/54582/ Dr. Kathleen Moore reviews the clinical significance of HER2 expression across diverse solid tumors and its role in guiding treatment decisions. She outlines HER2 testing methodologies, including immu...

CME credits: 0.25 Valid until: 01-06-2027 Claim your CME credit at https://reachmd.com/programs/cme/chairpersons-perspective-reframing-first-line-and-subsequent-care-in-advanced-urothelial-carcinoma-clinical-implications-of-the-updated-nccn-guidelines/54396/ This 15-minute online CME activity reviews the clinical implications of the updated NCCN Guidelines for advanced urothelial carcinoma (aUC),...